ArticleOncoTargets and therapy2020

miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway.

Qing-Ping Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.